Your browser doesn't support javascript.
Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 with grinch.
O'Toole, Áine; Hill, Verity; Pybus, Oliver G; Watts, Alexander; Bogoch, Issac I; Khan, Kamran; Messina, Jane P; Tegally, Houriiyah; Lessells, Richard R; Giandhari, Jennifer; Pillay, Sureshnee; Tumedi, Kefentse Arnold; Nyepetsi, Gape; Kebabonye, Malebogo; Matsheka, Maitshwarelo; Mine, Madisa; Tokajian, Sima; Hassan, Hamad; Salloum, Tamara; Merhi, Georgi; Koweyes, Jad; Geoghegan, Jemma L; de Ligt, Joep; Ren, Xiaoyun; Storey, Matthew; Freed, Nikki E; Pattabiraman, Chitra; Prasad, Pramada; Desai, Anita S; Vasanthapuram, Ravi; Schulz, Thomas F; Steinbrück, Lars; Stadler, Tanja; Parisi, Antonio; Bianco, Angelica; García de Viedma, Darío; Buenestado-Serrano, Sergio; Borges, Vítor; Isidro, Joana; Duarte, Sílvia; Gomes, João Paulo; Zuckerman, Neta S; Mandelboim, Michal; Mor, Orna; Seemann, Torsten; Arnott, Alicia; Draper, Jenny; Gall, Mailie; Rawlinson, William; Deveson, Ira.
  • O'Toole Á; Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK.
  • Hill V; Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK.
  • Pybus OG; Department of Zoology, University of Oxford, Oxford, UK.
  • Watts A; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.
  • Bogoch II; BlueDot, Toronto, Canada.
  • Khan K; Department of Medicine, University of Toronto, Toronto, Canada.
  • Messina JP; Divisions of General Internal Medicine and Infectious Diseases, University Health Network, Toronto, Canada.
  • Tegally H; Department of Geography, University of Oxford, Oxford, UK.
  • Tumedi KA; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Nyepetsi G; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Kebabonye M; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Matsheka M; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Mine M; Botswana Institute for Technology Research and Innovation, Gaborone, Botswana.
  • Tokajian S; National Health Laboratory, Gaborone, Botswana.
  • Hassan H; Ministry of Health and Wellness, Gaborone, Botswana.
  • Salloum T; Botswana Institute for Technology Research and Innovation, Gaborone, Botswana.
  • Merhi G; National Health Laboratory, Gaborone, Botswana.
  • Koweyes J; Department of Natural Sciences, Lebanese American University, Beirut, Lebanon.
  • Geoghegan JL; Faculty of Public Health, Lebanese University, Beirut, Lebanon.
  • de Ligt J; Department of Natural Sciences, Lebanese American University, Beirut, Lebanon.
  • Ren X; Department of Natural Sciences, Lebanese American University, Beirut, Lebanon.
  • Storey M; Department of Natural Sciences, Lebanese American University, Beirut, Lebanon.
  • Freed NE; Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
  • Pattabiraman C; Institute of Environmental Science and Research, Wellington, New Zealand.
  • Prasad P; Institute of Environmental Science and Research, Wellington, New Zealand.
  • Desai AS; Institute of Environmental Science and Research, Wellington, New Zealand.
  • Vasanthapuram R; Institute of Environmental Science and Research, Wellington, New Zealand.
  • Schulz TF; School of Natural and Computational Sciences, Massey University, Auckland, New Zealand.
  • Steinbrück L; Department of Neurovirology, National Institute of Mental Health and Neurosciences, Bengaluru, India.
  • Stadler T; Department of Neurovirology, National Institute of Mental Health and Neurosciences, Bengaluru, India.
  • Parisi A; Department of Neurovirology, National Institute of Mental Health and Neurosciences, Bengaluru, India.
  • Bianco A; Institute of Virology, Hannover Medical School, Hannover, Germany.
  • García de Viedma D; Institute of Virology, Hannover Medical School, Hannover, Germany.
  • Buenestado-Serrano S; Department of Biosystems Science and Engineering, ETH Zürich, Zurich, Switzerland.
  • Isidro J; Istituto Zooprofilattico sperimentale della Puglia e della Basilicata, Puglia, Italy.
  • Duarte S; Istituto Zooprofilattico sperimentale della Puglia e della Basilicata, Puglia, Italy.
  • Gomes JP; Hospital General Universitario Gregorio Marañón; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
  • Zuckerman NS; CIBER Enfermedades Respiratorias CIBERES, Madrid, Spain.
  • Mandelboim M; Hospital General Universitario Gregorio Marañón; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
  • Mor O; Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Seemann T; Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Arnott A; Innovation and Technology Unit, Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Draper J; Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
  • Gall M; Central Virology Laboratory, Israel Ministry of Health, Sheba Medical Center, Ramat Gan, Israel.
  • Rawlinson W; Central Virology Laboratory, Israel Ministry of Health, Sheba Medical Center, Ramat Gan, Israel.
  • Deveson I; Central Virology Laboratory, Israel Ministry of Health, Sheba Medical Center, Ramat Gan, Israel.
Wellcome Open Res ; 6: 121, 2021.
Article in English | MEDLINE | ID: covidwho-1450989
ABSTRACT
Late in 2020, two genetically-distinct clusters of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with mutations of biological concern were reported, one in the United Kingdom and one in South Africa. Using a combination of data from routine surveillance, genomic sequencing and international travel we track the international dispersal of lineages B.1.1.7 and B.1.351 (variant 501Y-V2). We account for potential biases in genomic surveillance efforts by including passenger volumes from location of where the lineage was first reported, London and South Africa respectively. Using the software tool grinch (global report investigating novel coronavirus haplotypes), we track the international spread of lineages of concern with automated daily reports, Further, we have built a custom tracking website (cov-lineages.org/global_report.html) which hosts this daily report and will continue to include novel SARS-CoV-2 lineages of concern as they are detected.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Topics: Variants Language: English Journal: Wellcome Open Res Year: 2021 Document Type: Article Affiliation country: Wellcomeopenres.16661.2

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Topics: Variants Language: English Journal: Wellcome Open Res Year: 2021 Document Type: Article Affiliation country: Wellcomeopenres.16661.2